| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |